Xingliang Tan, Yanjun Wang, Zhiming Wu, Wensu Wei, Qianghua Zhou, Chichen Zhang, Xinpei Deng, Runhao Zheng, Jiamin Zeng, Qiuhong Chen, Kai Yao. "Formula-01: A phase Ⅱ study of disitamab vedotin (RC48) intravenous injection combined with BCG intravesical instillation in high-risk non-muscle invasive bladder cancer with HER2 high expression.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps894